ProMab Biotechnologies Revenue and Competitors
Estimated Revenue & Valuation
- ProMab Biotechnologies's estimated annual revenue is currently $3.1M per year.
- ProMab Biotechnologies's estimated revenue per employee is $163,158
Employee Data
- ProMab Biotechnologies has 19 Employees.
- ProMab Biotechnologies grew their employee count by 19% last year.
ProMab Biotechnologies's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
4 | Associate Researcher | Reveal Email/Phone |
5 | Research Associate | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Associate Researcher | Reveal Email/Phone |
8 | Client and Marketing Specialist | Reveal Email/Phone |
9 | Research Associate | Reveal Email/Phone |
ProMab Biotechnologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is ProMab Biotechnologies?
ProMab Biotechnologies (PMB) develops and commercializes recombinant proteins, antibodies, and engineered cell lines through the integration of bioinformatics, molecular biology, protein expression, purification techniques, gene cloning, microbiology, and immunology, using novel high-throughput technologies. PMB provides its proprietary proteins, engineered cell lines, and antibodies to deliver innovative research and diagnostic products, as well as services for the global biomedical research community through collaborations, partnerships, and joint ventures with other biotechnology and bio-reagent companies. PMB is on target to be one of the leading suppliers of bio-reagents in the twenty-first century and is committed to improving human health with a focus on the field of immunotherapy, specifically CAR-T/NK cell technologies. ProMab Biotechnologies seeks partnership with academic researchers, biotechnology and pharmaceutical companies around the world. We will achieve our goal of being distinguished within the scientific community by continuing to build a superior reputation for quality, reliability, promptness, and cost-effective products and services.
keywords:N/AN/A
Total Funding
19
Number of Employees
$3.1M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 19 | 0% | N/A |
#2 | $1M | 19 | 27% | N/A |
#3 | $2.5M | 19 | -14% | N/A |
#4 | N/A | 19 | 6% | N/A |
#5 | N/A | 19 | 12% | N/A |